Denver Investment Advisors’s Anixa Biosciences ANIX Stock Holding History

Denver Investment Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$67K	Hold	17,400	–	–	﹤0.01%	410
2017 Q4	$41K	Hold	17,400	–	–	﹤0.01%	423
2017 Q3	$46K	Sell	17,400 -1,080	-6%	-$1.19K	﹤0.01%	440
2017 Q2	$21K	Hold	18,480	–	–	﹤0.01%	447
2017 Q1	$55K	Hold	18,480	–	–	﹤0.01%	458
2016 Q4	$100K	Hold	18,480	–	–	﹤0.01%	459
2016 Q3	$72K	Hold	18,480	–	–	﹤0.01%	434
2016 Q2	$58K	Hold	18,480	–	–	﹤0.01%	446
2016 Q1	$56K	Hold	18,480	–	–	﹤0.01%	459
2015 Q4	$56K	Buy	+18,480	New	+$64.8K	﹤0.01%	497

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CAM

Concorde Asset Management Ann Arbor, Michigan $204M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Denver Investment Advisors's ANIX Position: Q1 2018 in Review

Denver Investment Advisors held its Anixa Biosciences (ANIX) position steady in Q1 2018 at 17,400 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Denver Investment Advisors first reported a position in ANIX in Q4 2015 and has held it in 10 quarters since. The position peaked at $100K in Q4 2016. 18 funds tracked by Wall St. Rank hold ANIX as of Q1 2018.

Denver Investment Advisors held 17,400 shares of Anixa Biosciences worth $67K as of Q1 2018.
Denver Investment Advisors left its Anixa Biosciences share count unchanged in Q1 2018.
Anixa Biosciences made up ﹤0.01% of Denver Investment Advisors's portfolio in Q1 2018, its #410 holding.
Denver Investment Advisors first reported a position in Anixa Biosciences in Q4 2015 and has held it in 10 quarters since.
Denver Investment Advisors's Anixa Biosciences position peaked at $100K in Q4 2016.
18 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.